Luciano Burattini

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

Matteo Santoni, Ugo De Giorgi, Roberto Iacovelli et al. · British Journal of Cancer · 2013 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors

Matteo Santoni, Alessandro Conti, Stefano Partelli et al. · Annals of Surgical Oncology · 2014 · 92 citations

Medicine, Oncology, Surgery +16

High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer

Lorena Rossi, Matteo Santoni, Simon J. Crabb et al. · Annals of Surgical Oncology · 2014 · 84 citations

Medicine, Immunology, Oncology +10

Phase II Study of Oxaliplatin and Gemcitabine Salvage Chemotherapy in Patients with Cisplatin-Refractory Nonseminomatous Germ Cell Tumor

Ugo De Giorgi, Giovanni Rosti, Michele Aieta et al. · European Urology · 2006 · 80 citations

Medicine, Oncology, Chemotherapy +14

VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib

Mario Scartozzi, Maristella Bianconi, Luca Faloppi et al. · British Journal of Cancer · 2012 · 78 citations · Full text

Medicine, Oncology, Cancer Genetics +16